SCLE and Dermatomyositis in Anti‐PD‐1 Therapy

British Journal of Dermatology - United Kingdom
doi 10.1111/bjd.18280
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Scle 和皮肌炎与抗 Pd‐1 治疗

British Journal of Dermatology
DermatologyMedicine
2019English

Effect of Combined Anti-Pd-1 and Temozolomide Therapy in Glioblastoma

OncoImmunology
OncologyAllergyImmunology
2018English

Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy

Clinical Cancer Research
Cancer ResearchOncology
2017English

Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2020English

Ineffective Anti PD-1 Therapy After BRAF Inhibitor Failure in Advanced Melanoma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Long-Term Survival in Patients Responding to Anti-Pd-1/Pd-L1 Therapy and Disease Outcome Upon Treatment Discontinuation

Clinical Cancer Research
Cancer ResearchOncology
2019English

Efficacy of Chemotherapy or Chemo-Anti-Pd-1 Combination After Failed Anti-Pd-1 Therapy for Relapsed and Refractory Hodgkin Lymphoma: A Series From Lysa Centers

American Journal of Hematology
Hematology
2018English

Oncolytic Virus and PD-1/PD-L1 Blockade Combination Therapy

Oncolytic Virotherapy
2018English

Association Between Immune-Related Adverse Events During Anti–PD-1 Therapy and Tumor Mutational Burden

JAMA Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy